Corlux Second Phase III Trial Enrolled For Psychotic Major Depression
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Data from three Phase III trials of Corcept's Corlux for psychotic major depression will be available by year-end, the firm said